BACKGROUND: Approximately two thirds of patients undergoing capsule endoscopy for obscure GI bleeding will have an abnormality found in the small intestine. This report describes 9 patients (4 men, 5 women) of 140 with obscure bleeding in whom a source of their blood loss was found in the stomach or the colon at capsule endoscopy. METHODS: A review was made of a prospective database of 140 consecutive patients undergoing capsule endoscopy for obscure GI bleeding at a single center. Patients with a definite or likely cause of bleeding within reach of conventional upper or lower GI endoscopy were identified. RESULTS: Three patients had gastric antral vascular ectasia and another an inflamed pyloric canal polyp. Two patients had actively bleeding cecal carcinoma, missed at previous colonoscopies. Two others had bleeding cecal angiodysplasia. The final patient had severe nonspecific cecal inflammation. The identification of these lesions was aided by the suspected blood indicator. All patients underwent endoscopic therapy or surgery for their non-small-bowel lesions. CONCLUSIONS: Like push enteroscopy, capsule endoscopy also can identify lesions within reach of conventional endoscopy and colonoscopy. These subsequently can be treated successfully. The reasons why these lesions have been missed are unclear.
BACKGROUND: Approximately two thirds of patients undergoing capsule endoscopy for obscure GI bleeding will have an abnormality found in the small intestine. This report describes 9 patients (4 men, 5 women) of 140 with obscure bleeding in whom a source of their blood loss was found in the stomach or the colon at capsule endoscopy. METHODS: A review was made of a prospective database of 140 consecutive patients undergoing capsule endoscopy for obscure GI bleeding at a single center. Patients with a definite or likely cause of bleeding within reach of conventional upper or lower GI endoscopy were identified. RESULTS: Three patients had gastric antral vascular ectasia and another an inflamed pyloric canal polyp. Two patients had actively bleeding cecal carcinoma, missed at previous colonoscopies. Two others had bleeding cecal angiodysplasia. The final patient had severe nonspecific cecal inflammation. The identification of these lesions was aided by the suspected blood indicator. All patients underwent endoscopic therapy or surgery for their non-small-bowel lesions. CONCLUSIONS: Like push enteroscopy, capsule endoscopy also can identify lesions within reach of conventional endoscopy and colonoscopy. These subsequently can be treated successfully. The reasons why these lesions have been missed are unclear.
Authors: Salmaan Jawaid; Neil Marya; Bilal Gondal; Louise Maranda; Christopher Marshall; Joseph Charpentier; Abbas Rupawala; Muhammad Al-Sayid; Anupam Singh; Anne Foley; Gregory Volturo; David Cave Journal: Dig Dis Sci Date: 2018-08-22 Impact factor: 3.199
Authors: Laura Marelli; Francesca Maria Jaboli; Linda Jackson; Hansa Palmer; Gamal Erian; Mark Hamilton; Owen Epstein Journal: Frontline Gastroenterol Date: 2012-12-19
Authors: Ignacio Fernandez-Urien; Erika Borobio; Inmaculada Elizalde; Rebeca Irisarri; Juan Jose Vila; Jesus Maria Urman; Javier Jimenez Journal: World J Gastroenterol Date: 2010-01-07 Impact factor: 5.742
Authors: E Estévez; B González-Conde; J L Vázquez-Iglesias; P A Alonso; M de los Angeles Vázquez-Millán; R Pardeiro Journal: Surg Endosc Date: 2007-03-14 Impact factor: 3.453